5.9 C
New York
Friday, March 29, 2024

SunTrust Robinson Humphrey Upgrades Amedisys To Buy

Courtesy of Benzinga.

Related AMED
Top 4 NASDAQ Stocks In The Home Health Care Industry With The Highest EPS
Top 4 Small-Cap Stocks In The Home Health Care Industry With The Highest EPS

Analysts at SunTrust Robinson Humphrey upgraded Amedisys Inc (NASDAQ: AMED) from Neutral to Buy.

The price target for Amedisys has been raised from $31.00 to $36.00.

Amedisys shares have gained 98.98 percent over the past 52 weeks, while the S&P 500 index has surged 10.18 percent in the same period.

Amedisys shares climbed 0.52 percent to close at $29.13 yesterday.

Latest Ratings for AMED

Date Firm Action From To
May 2015 SunTrust Robinson Humphrey Upgrades Neutral Buy
Apr 2015 Deutsche Bank Maintains Hold
Mar 2015 Jefferies Maintains Hold

View More Analyst Ratings for AMED
View the Latest Analyst Ratings

Posted-In: SunTrust Robinson HumphreyUpgrades Analyst Ratings

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,450FansLike
396,312FollowersFollow
2,280SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x